Xiangrong Wu
Overview
Explore the profile of Xiangrong Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
287
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jiang Y, Lin Y, Wen Y, Fu W, Wang R, He J, et al.
J Thorac Dis
. 2023 Mar;
15(2):348-364.
PMID: 36910098
Background: Esophageal cancer is one of the leading causes of cancer death worldwide. A deeper understanding of the trends in annual incidence, mortality, and disability-adjusted life-years (DALYs) of esophageal cancer...
12.
Li C, Li J, Xiong S, Zhou H, Cai X, Xie Z, et al.
J Cancer Res Clin Oncol
. 2023 Feb;
149(10):6857-6873.
PMID: 36809502
Introduction: A comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies was performed to map the different risk factors and assess the causality for lung cancer. Methods: Systematic reviews and...
13.
Peng H, Wu X, Liu S, He M, Xie C, Zhong R, et al.
Clin Transl Med
. 2023 Jan;
13(1):e1155.
PMID: 36588094
Background: Conventional immunohistochemistry technologies were limited by the inability to simultaneously detect multiple markers and the lack of identifying spatial relationships among cells, hindering understanding of the biological processes in...
14.
Wu X, Zhu J, Lin F, Fang Z, Zhu X
ACS Omega
. 2022 Dec;
7(49):44743-44749.
PMID: 36530222
We demonstrate that a high-index dielectric Si metasurface with a designed chiral unit structure possesses an exceptional point (EP) when it is described by a non-Hermitian Hamiltonian associated with the...
15.
Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis
Wen Y, Jiang T, Wu X, Peng H, Ren S, Zhou C
Ther Adv Med Oncol
. 2022 Aug;
14:17588359221116607.
PMID: 36032351
Background: It remains unknown what is the optimal front-line choice for advanced non-small-cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) fusion. Methods: We conducted a systematic review and network...
16.
Feng Y, Wang R, Li C, Cai X, Huo Z, Liu Z, et al.
Transl Lung Cancer Res
. 2022 Aug;
11(7):1302-1314.
PMID: 35958335
Background: Previous studies have shown that metabolites play important roles in phenotypic regulation, but the causal link between metabolites and tumors has not been examined adequately. Herein, we investigate the...
17.
Ao Y, Wen Y, Li Y, Peng H, Wu X, Wang Z, et al.
Front Genet
. 2022 Aug;
13:861984.
PMID: 35910198
It remains uncertain whether ankylosing spondylitis is associated with an increased risk of lung cancer. We conducted a meta-analysis to comprehensively evaluate the correlation between ankylosing spondylitis and lung cancer...
18.
Peng H, Wu X, Xiong S, Li C, Zhong R, He J, et al.
J Infect
. 2022 Jun;
85(3):e59-e61.
PMID: 35724757
No abstract available.
19.
Wu X, Peng H, Xiong S, Li C, Zhong R, He J, et al.
J Infect
. 2022 May;
85(1):e1-e3.
PMID: 35561867
No abstract available.
20.
Peng H, Wu X, Wen Y
Front Med (Lausanne)
. 2022 Apr;
9:792008.
PMID: 35402429
Background: Observational studies indicated that circulating vitamin C (VitC) levels may be correlated with the risk of endometrial cancer (EC). However, the causal effects and direction between them were still...